Literature DB >> 11024541

Sequential expression of chemokines in experimental autoimmune neuritis.

B C Kieseier1, K Krivacic, S Jung, H Pischel, K V Toyka, R M Ransohoff, H P Hartung.   

Abstract

Recruitment of inflammatory cells is of critical importance in the pathogenesis of immune-mediated demyelinating diseases in the peripheral nervous system (PNS). Evidence is increasing that chemokines might play a key role in this process, since they promote leukocyte entry into the nervous system during immune-mediated inflammation. In the present study we report the expression pattern of the chemokines interferon-gamma-inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and regulated upon activation normal T cell expressed and secreted (RANTES) in sciatic nerves from animals with myelin-induced experimental autoimmune neuritis, using a semiquantitative reverse transcriptase-PCR dot-blot hybridization assay. The mRNAs for MIP-1alpha and MIP-1beta were found to be upregulated with peak values at day 13 post-immunization (p.i.), preceding maximum disease severity. In contrast, mRNAs for MCP-1, RANTES, and IP-10 exhibited peak levels coincident with peak of the disease at day 15 p.i. Increased mRNA expression was associated with enhanced protein levels, as demonstrated by immunoblotting for each chemokine investigated. Immunohistochemistry for IP-10 protein revealed immunoreactivity associated with perineurial endothelial cells. RANTES protein was localized immunohistologically to invading T lymphocytes. Our findings suggest that chemokines, which act towards T cells and mononuclear phagocytes, are sequentially upregulated during the clinical course of EAN and thus may contribute to the pathogenesis of inflammatory demyelinating diseases of the PNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024541     DOI: 10.1016/s0165-5728(00)00323-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy.

Authors:  Hye-Jung Kim; Cha-Gyun Jung; Mark A Jensen; Danuta Dukala; Betty Soliven
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  TNF-α expression in Schwann cells is induced by LPS and NF-κB-dependent pathways.

Authors:  Yongwei Qin; Minhui Hua; Yinong Duan; Yongjing Gao; Xiaoyi Shao; Haibo Wang; Tao Tao; Aiguo Shen; Chun Cheng
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

4.  α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.

Authors:  Nejla Yosef; Eroboghene E Ubogu
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

Review 5.  The role of chemokines in Guillain-Barré syndrome.

Authors:  Sharon Chiang; Eroboghene E Ubogu
Journal:  Muscle Nerve       Date:  2013-07-27       Impact factor: 3.217

6.  Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  R Press; M Pashenkov; J P Jin; H Link
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

7.  Tumour necrosis factor α enhances CCL2 and ICAM-1 expression in peripheral nerve microvascular endoneurial endothelial cells.

Authors:  Kelly A Langert; Cynthia L Von Zee; Evan B Stubbs
Journal:  ASN Neuro       Date:  2013-02-06       Impact factor: 4.146

8.  Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.

Authors:  Gerd Meyer zu Hörste; Anne K Mausberg; Johanna I Müller; Helmar C Lehmann; Stefan Löber; Peter Gmeiner; Hans-Peter Hartung; Olaf Stüve; Carsten Korth; Bernd C Kieseier
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

9.  Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages.

Authors:  Anne K Mausberg; Gerd Meyer Zu Hörste; Thomas Dehmel; Mark Stettner; Helmar C Lehmann; Kazim A Sheikh; Bernd C Kieseier
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

10.  FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies.

Authors:  Gerd Meyer zu Hörste; Steffen Cordes; Anne K Mausberg; Alla L Zozulya; Carsten Wessig; Tim Sparwasser; Christian Mathys; Heinz Wiendl; Hans-Peter Hartung; Bernd C Kieseier
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.